A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis Patients

The Effect of Prophylactic Anticoagulation on Major Bleeding Events in Hospitalized Chronic Kidney Disease and Lower Limb Fracture Patients.

NCT06795698 ·Status: COMPLETED ·Phase: PHASE2

Dalteparin's Influence on Renally Compromised: Anti-Ten-A Study (DIRECT)

NCT00138099 ·Status: COMPLETED

Factor XI LICA to Reduce Events Such as Heart Attack and Stroke in Patients Whose Kidneys Are no Longer Able to Work as They Should and Require Treatment to Filter Wastes From the Blood: Focus is on the Safety of BAY2976217 and the Way the Body Absorbs, Distributes and Removes the Study Drug

NCT04534114 ·Status: COMPLETED ·Phase: PHASE2

Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses

NCT02719418 ·Status: COMPLETED

The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis

NCT00216866 ·Status: COMPLETED ·Phase: PHASE2

Validation of a Novel Dabigatran Based Peri-Operative Bridging Anticoagulation Protocol for Patients on Chronic Warfarin Therapy

NCT01810237 ·Status: WITHDRAWN ·Phase: NA

A Study in Participants With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants (Extension Study)

NCT02329327 ·Status: COMPLETED ·Phase: PHASE3

The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis

NCT03862859 ·Status: RECRUITING ·Phase: PHASE4

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With and Without Renal Impairment

NCT02182024 ·Status: COMPLETED ·Phase: PHASE1

Reversal of Dabigatran With Prothrombin Complex Concentrate

NCT02463591 ·Status: UNKNOWN ·Phase: PHASE2

Low Molecular Weight Heparin in Prevention of Recurrent Arteriovenous Graft Thrombosis in Chronic Hemodialysis Patients.

NCT01970280 ·Status: UNKNOWN ·Phase: PHASE4

Retrospective Study on Characteristics and Outcomes in Hospitalised Patients Treated With Ondexxya

NCT05898412 ·Status: COMPLETED

Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome

NCT04850378 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Bleeding Risk Evaluation in Haemophilia Patients Under Antiplatelet Therapies

NCT03157154 ·Status: COMPLETED

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

NCT01184989 ·Status: COMPLETED ·Phase: PHASE4

Thrombosis and Haemorrhage in Chronic Hemodialysis Patients

NCT02897258 ·Status: COMPLETED

Long Study - Longitudinal Thrombosis in End Stage Renal Disease

NCT00157664 ·Status: UNKNOWN

Study of Apixaban in Patients Receiving Hemodiafiltration

NCT04952792 ·Status: COMPLETED ·Phase: PHASE2

Low Molecular Weight Heparin for 72 Hours Followed by Dabigatran for Acute Intermediate-Risk Pulmonary Embolism.

NCT02596555 ·Status: TERMINATED ·Phase: PHASE4

Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia

NCT01727401 ·Status: TERMINATED ·Phase: PHASE4

Assays for and Reversal of New Anticoagulants

NCT01795781 ·Status: COMPLETED

Early Versus Late Resumption of Anticoagulation in Patients With Both High Thrombosis Risk and Major HEmoRrhage

NCT02091479 ·Status: TERMINATED ·Phase: PHASE3

Study of Low Molecular Weight Heparins

NCT06020560 ·Status: UNKNOWN ·Phase: PHASE4

Efficacy and Safety of Prothromplex Total (Prothrombin Complex Concentrate) in Oral Anticoagulant Reversal

NCT01159210 ·Status: COMPLETED ·Phase: PHASE4

Rt-PA Infusion Versus Catheter Exchange for Dialysis Catheter Malfunction Due to Fibrin Sheath

NCT00194181 ·Status: TERMINATED ·Phase: NA